Next Generation Cancer Diagnostics Market - Industry Analysis, Market Size, Share, Trends, Application Analysis, Growth And Forecast 2019 - 2024

Report Code: HCR 97294 Report Format: PDF + Excel Database
1. Next Generation Cancer Diagnostics Market - Overview
        1.1 Definitions and Scope
2. Next Generation Cancer Diagnostics Market - Executive summary
        2.1 Market Revenue, Market Size and Key Trends by Company
        2.2 Key Trends by type of Application
        2.3 Key Trends segmented by Geography
3. Next Generation Cancer Diagnostics Market
        3.1 Comparative analysis
            3.1.1 Product Benchmarking - Top 10 companies
            3.1.2 Top 5 Financials Analysis
            3.1.3 Market Value split by Top 10 companies
            3.1.4 Patent Analysis - Top 10 companies
            3.1.5 Pricing Analysis
4. Next Generation Cancer Diagnostics Market - Startup companies Scenario Premium
        4.1 Top 10 startup company Analysis by
            4.1.1 Investment
            4.1.2 Revenue
            4.1.3 Market Shares
            4.1.4 Market Size and Application Analysis
            4.1.5 Venture Capital and Funding Scenario
5. Next Generation Cancer Diagnostics Market - Industry Market Entry Scenario Premium
        5.1 Regulatory Framework Overview
        5.2 New Business and Ease of Doing business index
        5.3 Case studies of successful ventures
        5.4 Customer Analysis - Top 10 companies
6. Next Generation Cancer Diagnostics Market Forces
        6.1 Drivers
        6.2 Constraints
        6.3 Challenges
        6.4 Porters five force model
            6.4.1 Bargaining power of suppliers
            6.4.2 Bargaining powers of customers
            6.4.3 Threat of new entrants
            6.4.4 Rivalry among existing players
            6.4.5 Threat of substitutes
7. Next Generation Cancer Diagnostics Market - Strategic analysis
        7.1 Value chain analysis
        7.2 Opportunities analysis
        7.3 Product life cycle
        7.4 Suppliers and distributors Market Share
8. Next Generation Cancer Diagnostics Market - By Technology (Market Size -$Million / $Billion)
        8.1 NGS-based cancer diagnostics
        8.2 qPCR & Multiplexing
        8.3 Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
        8.4 Protein microarrays-based cancer diagnostics
        8.5 DNA microarrays-based cancer diagnostics
9. Next Generation Cancer Diagnostics Market - By Type (Market Size -$Million / $Billion)
        9.1 Next Generation Cancer Diagnostics By Cancer Type
            9.1.1 Lung Cancer
            9.1.2 Breast Cancer
            9.1.3 Colorectal Cancer
            9.1.4 Cervical Cancer
            9.1.5 Other Type Of Cancer
        9.2 Next Generation Cancer Diagnostics By Function Type
            9.2.1 Therapeutic Monitoring
            9.2.2 Companion Diagnostics
            9.2.3 Prognostic Diagnostics
            9.2.4 Cancer Screening
            9.2.5 Risk Analysis
10. Next Generation Cancer Diagnostics - By Application (Market Size -$Million / $Billion)
        10.1 Segment type Size and Market Share Analysis
        10.2 Application Revenue and Trends by type of Application
        10.3 Application Segment Analysis by Type
            10.3.1 Next Generation Cancer Diagnostics Revenue Share By Application
            10.3.2 Biomarker Development
            10.3.3 Ctc Analysis
            10.3.4 Proteomic Analysis
            10.3.5 Epigenetic Analysis
            10.3.6 Genetic Analysis
11. Next Generation Cancer Diagnostics - By Geography (Market Size -$Million / $Billion)
        11.1 Next Generation Cancer Diagnostics Market - North America Segment Research
        11.2 North America Market Research (Million / $Billion)
            11.2.1 Segment type Size and Market Size Analysis
            11.2.2 Revenue and Trends
            11.2.3 Application Revenue and Trends by type of Application
            11.2.4 Company Revenue and Product Analysis
            11.2.5 North America Product type and Application Market Size
                  11.2.5.1 U.S
                  11.2.5.2 Canada
                  11.2.5.3 Mexico
                  11.2.5.4 Rest of North America
        11.3 Next Generation Cancer Diagnostics- South America Segment Research
        11.4 South America Market Research (Market Size -$Million / $Billion)
            11.4.1 Segment type Size and Market Size Analysis
            11.4.2 Revenue and Trends
            11.4.3 Application Revenue and Trends by type of Application
            11.4.4 Company Revenue and Product Analysis
            11.4.5 South America Product type and Application Market Size
                  11.4.5.1 Brazil
                  11.4.5.2 Venezuela
                  11.4.5.3 Argentina
                  11.4.5.4 Ecuador
                  11.4.5.5 Peru
                  11.4.5.6 Colombia
                  11.4.5.7 Costa Rica
                  11.4.5.8 Rest of South America
        11.5 Next Generation Cancer Diagnostics- Europe Segment Research
        11.6 Europe Market Research (Market Size -$Million / $Billion)
            11.6.1 Segment type Size and Market Size Analysis
            11.6.2 Revenue and Trends
            11.6.3 Application Revenue and Trends by type of Application
            11.6.4 Company Revenue and Product Analysis
            11.6.5 Europe Segment Product type and Application Market Size
                  11.6.5.1 U.K
                  11.6.5.2 Germany
                  11.6.5.3 Italy
                  11.6.5.4 France
                  11.6.5.5 Netherlands
                  11.6.5.6 Belgium
                  11.6.5.7 Denmark
                  11.6.5.8 Spain
                  11.6.5.9 Rest of Europe
        11.7 Next Generation Cancer Diagnostics - APAC Segment Research
        11.8 APAC Market Research (Market Size -$Million / $Billion)
            11.8.1 Segment type Size and Market Size Analysis
            11.8.2 Revenue and Trends
            11.8.3 Application Revenue and Trends by type of Application
            11.8.4 Company Revenue and Product Analysis
            11.8.5 APAC Segment - Product type and Application Market Size
                  11.8.5.1 China
                  11.8.5.2 Australia
                  11.8.5.3 Japan
                  11.8.5.4 South Korea
                  11.8.5.5 India
                  11.8.5.6 Taiwan
                  11.8.5.7 Malaysia
                  11.8.5.8 Hong kong
                  11.8.5.9 Rest of APAC
        11.9 Next Generation Cancer Diagnostics - Middle East Segment and Africa Segment Research
        11.10 Middle East & Africa Market Research (Market Size -$Million / $Billion)
            11.10.1 Segment type Size and Market Size Analysis
            11.10.2 Revenue and Trend Analysis
            11.10.3 Application Revenue and Trends by type of Application
            11.10.4 Company Revenue and Product Analysis
            11.10.5 Middle East Segment Product type and Application Market Size
                  11.10.5.1 Israel
                  11.10.5.2 Saudi Arabia
                  11.10.5.3 UAE
            11.10.6 Africa Segment Analysis
                  11.10.6.1 South Africa
                  11.10.6.2 Rest of Middle East & Africa
12. Next Generation Cancer Diagnostics Market - Entropy
        12.1 New product launches
        12.2 M&A s, collaborations, JVs and partnerships
13. Next Generation Cancer Diagnostics Market - Industry / Segment Competition landscape Premium
        13.1 Market Share Analysis
            13.1.1 Market Share by Country- Top companies
            13.1.2 Market Share by Region- Top 10 companies
            13.1.3 Market Share by type of Application - Top 10 companies
            13.1.4 Market Share by type of Product / Product category- Top 10 companies
            13.1.5 Market Share at global level - Top 10 companies
            13.1.6 Best Practises for companies
14. Next Generation Cancer Diagnostics Market - Key Company List by Country Premium
15. Next Generation Cancer Diagnostics Market Company Analysis
        15.1 Market Share, Company Revenue, Products, M&A, Developments
        15.2 Alkermes
        15.3 Allergan / Geodon Ritcher
        15.4 Astrazeneca
        15.5 Bristol-Myers Squibb And Company/ Otsuka Pharmaceutical
        15.6 Eli Lilly
        15.7 Johnson Johnson
        15.8 Pfizer
        15.9 Sumitomo Dainippon Pharma
        15.10 Summary
        15.11 Vanda Pharmaceutical
        15.12 Company 11
        15.13 Company 12 & More
*Financials would be provided on a best efforts basis for private companies
16. Next Generation Cancer Diagnostics Market - Appendix
        16.1 Abbreviations
        16.2 Sources
17. Next Generation Cancer Diagnostics Market - Methodology
        17.1 Research Methodology
            17.1.1 Company Expert Interviews
            17.1.2 Industry Databases
            17.1.3 Associations
            17.1.4 Company News
            17.1.5 Company Annual Reports
            17.1.6 Application Trends
            17.1.7 New Products and Product database
            17.1.8 Company Transcripts
            17.1.9 R&D Trends
            17.1.10 Key Opinion Leaders Interviews
            17.1.11 Supply and Demand Trends

List of Tables

1 US Next Generation Cancer Diagnostics Market Size 2018
2 Canada Next Generation Cancer Diagnostics Market Share 2018
3 Brazil Next Generation Cancer Diagnostics Market Outlook 2019 - 2023
4 Mexico Next Generation Cancer Diagnostics Market Research 2018
5 Germany Next Generation Cancer Diagnostics Market Trends 2019 - 2023 
6 France Next Generation Cancer Diagnostics Market Growth 2019 - 2023 
7 UK Next Generation Cancer Diagnostics Market Demand 2019 - 2023 
8 Italy Next Generation Cancer Diagnostics Market Segmentation 2018
9 Russia Next Generation Cancer Diagnostics Market Analysis 2019 - 2023
10 China Next Generation Cancer Diagnostics Market Revenue 2019 - 2023
11 Japan Next Generation Cancer Diagnostics Market Volume 2019 - 2023
12 South Korea Next Generation Cancer Diagnostics Market Potential 2019 - 2023
13 India Next Generation Cancer Diagnostics Market Leaders 2018
14 Saudi Arabia Next Generation Cancer Diagnostics Market Forecast 2019 - 2023 
15 Kuwait Next Generation Cancer Diagnostics Market Value 2018

List of Figures

For complete list of 60+ tables and 60+ figures follow the Link